NCT05171478
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +12 more
- Locations
-
- Johns Hopkins Hospital Baltimore, Maryland, United States
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,967 public trials
1,828 recruiting studies
Lymphatic Diseases trial results
NCT06387121
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
Recruiting
Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
NCT07284927
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07285590
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Instituto Português de Oncologia de Lisboa Francisco Gentil Lisbon, Lisbon District, Portugal
- Unidade Local De Saude De Santa Maria E.P.E. Lisbon, Lisbon District, Portugal
- INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol. Badalona, Barcelona, Spain
- Hospital Universitari Vall d'Hebron Barcelona, Spain
NCT07189065
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Anhui Cancer Hospital (West Branch of Anhui Provincial Hospital) Hefei, Anhui, China
- Beijing Shijitan Hospital Beijing, Beijing Municipality, China
- Beijing Tongren Hospital Beijing, Beijing Municipality, China
- National Cancer Center/Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT05901974
- Conditions
- Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- The First Affliated Hospital of Soochow University Suzhou, China
Recruiting
Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT06757647
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Recruiting
Amping up With PemJAK
NCT07283822
- Conditions
- Cutaneous T-Cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
Recruiting
Mosunetuzumab for CLL MRD Clearance
NCT07052695
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Brigham & Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01962415
- Conditions
- Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +125 more
- Locations
-
- UPMC Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States